Literature DB >> 16883537

[CHEK2 c.1100delC may not contribute to genetic background of hereditary breast cancer from Shanghai of China].

Chuan-gui Song1, Zhen Hu, Wen-tao Yuan, Gen-hong Di, Zhen-zhou Shen, Wei Huang, Zhi-ming Shao.   

Abstract

OBJECTIVE: To investigate the prevalence of CHEK2 c.1100delC mutation among non-BRCA1/BRCA2 familial/early-onset breast cancer patients in Shanghai.
METHODS: One hundred and fourteen non-BRCA1/BRCA2 hereditary breast cancer patients were analyzed, among whom 76 cases had at least one first-degree relative affected with breast cancer and 38 cases were diagnosed as breast cancer below the age of 40 years without family history. The mutation genotyping of CHEK2 c.1100delC were carried out through long-range PCR amplifying of exons 10-14, and followed by amplification of exon 10 and then DNA direct sequencing.
RESULTS: No c.1100delC frame-shift mutation was identified in our studied population. One novel missense mutation 1111C>T (p.His371Tyr), located in kinase catalytic domain, was found in 3 familial breast cancer cases but no one in control group.
CONCLUSION: CHEK2 c.1100delC is rare variant for Chinese population and may not contribute to predisposition for hereditary breast cancer in Shanghai. Novel variant -1111C>T could be in association with genetic susceptibility to breast cancer. A further study is needed to confirm the results.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16883537

Source DB:  PubMed          Journal:  Zhonghua Yi Xue Yi Chuan Xue Za Zhi        ISSN: 1003-9406


  7 in total

1.  Association Between CHEK2*1100delC and Breast Cancer: A Systematic Review and Meta-Analysis.

Authors:  Mingming Liang; Yun Zhang; Chenyu Sun; Feras Kamel Rizeq; Min Min; Tingting Shi; Yehuan Sun
Journal:  Mol Diagn Ther       Date:  2018-08       Impact factor: 4.074

2.  CHEK2*1100delC does not contribute to risk to breast cancer among Malay, Chinese and Indians in Malaysia.

Authors:  Eswary Thirthagiri; Leng San Cheong; Cheng Har Yip; Soo-Hwang Teo
Journal:  Fam Cancer       Date:  2009-04-28       Impact factor: 2.375

3.  Constitutional CHEK2 mutations are infrequent in early-onset and familial breast/ovarian cancer patients from Pakistan.

Authors:  Muhammad U Rashid; Noor Muhammad; Saima Faisal; Asim Amin; Ute Hamann
Journal:  BMC Cancer       Date:  2013-06-27       Impact factor: 4.430

4.  The CHEK2 1100delC allelic variant is not present in familial and sporadic breast cancer cases from Moroccan population.

Authors:  Chaymaa Marouf; Omar Hajji; Brehima Diakité; Amal Tazzite; Hassan Jouhadi; Abdellatif Benider; Sellama Nadifi
Journal:  Springerplus       Date:  2015-02-01

5.  Low prevalence of CHEK2 gene mutations in multiethnic cohorts of breast cancer patients in Malaysia.

Authors:  Suriati Mohamad; Nurismah Md Isa; Rohaizak Muhammad; Nor Aina Emran; Nor Mayah Kitan; Peter Kang; In Nee Kang; Nur Aishah Mohd Taib; Soo Hwang Teo; Sharifah Noor Akmal
Journal:  PLoS One       Date:  2015-01-28       Impact factor: 3.240

6.  An association study between CHEK2 gene mutations and susceptibility to breast cancer.

Authors:  Manizheh Jalilvand; Mana Oloomi; Reza Najafipour; Safar Ali Alizadeh; Najmaldin Saki; Fatemeh Samiee Rad; Mohammad Shekari
Journal:  Comp Clin Path       Date:  2017-04-08

Review 7.  Hereditary breast cancer in the Han Chinese population.

Authors:  Wenming Cao; Xiaojia Wang; Ji-Cheng Li
Journal:  J Epidemiol       Date:  2013-01-12       Impact factor: 3.211

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.